Studies of growth control and gene expression in normal and neoplastic B-lymphoid cells
- Prosjektnummer
- 3a-122
- Ansvarlig person
- Erlend B. Smeland
- Institusjon
- Rikshospitalet HF
- Prosjektkategori
- Fritt forskningsprosjekt
- Helsekategori
- Oncogenesis & Cancer Research
- Forskningsaktivitet
- Laboratoriebasert somatisk
Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.
Br J Haematol 2007 Feb;136(3):400-13. Epub 2006 des 8
PMID: 17156404
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007 Jun;109(11):4599-606. Epub 2007 feb 13
PMID: 17299095
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
J Exp Med 2007 Mar;204(3):633-43. Epub 2007 mar 12
PMID: 17353367
Characterization of early stages of human B cell development by gene expression profiling.
J Immunol 2007 Sep;179(6):3662-71.
PMID: 17785802
Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.
Eur J Immunol 2007 Oct;37(10):2937-48.
PMID: 17899540
Characterization of signaling pathways in normal and malignant hematopoietic cells by microarray technologies
- Disputert:
- april 2007
- Hovedveileder:
- Erlend B. Smeland
Studies of tumor associated antigens and BMP-6 signalling in normal and neoplastic B cells
- Disputert:
- februar 2007
- Hovedveileder:
- Erlend B. Smeland
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport